Insider trading

Period: 120 months Stock: ASMB + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

85 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

85 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

85 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

85 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
85 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
85 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

85 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
30 Mar 2023
Delaney William E IV Chief Scientific Officer
Sold at will
$2.82K 3,421 at 0.82
3.8%
Not planned
30 Mar 2023
Bjorkquist Jeanette M Principal Accounting Officer
Sold at will
$637.16 774 at 0.82
3.1%
Not planned
27 Mar 2023
Okazaki Jason A CEO and President
Sold at will
$4.78K 4,693 at 1.02
4.4%
Not planned
8 Aug 2022
McHutchison John G Chief Executive Officer
Sold, plan not stated
$26.20K 12,314 at 2.13
6.0%
25 Jul 2022
Samar Michael P. Chief Financial Officer
Sold, plan not stated
$4.48K 2,020 at 2.22
2.5%
31 May 2022
Delaney William E IV Chief Scientific Officer
Sold, plan not stated
$8.00K 4,164 at 1.92
5.2%
30 Mar 2022
McHutchison John G CEO and President
Sold, plan not stated
$10.00K 4,614 at 2.17
2.2%
30 Mar 2022
Samar Michael P. Chief Financial Officer
Sold, plan not stated
$4.95K 2,285 at 2.17
2.9%
30 Mar 2022
Okazaki Jason A Chief Operating Officer
Sold, plan not stated
$2.75K 1,269 at 2.17
1.3%
30 Mar 2022
Delaney William E IV Chief Scientific Officer
Sold, plan not stated
$2.25K 1,038 at 2.17
1.3%
30 Mar 2022
Stamm Luisa M Chief Medical Officer
Sold, plan not stated
$2.25K 1,038 at 2.17
2.5%
28 Mar 2022
Okazaki Jason A Chief Operating Officer
Sold, plan not stated
$10.36K 4,617 at 2.24
6.7%
9 Aug 2021
McHutchison John G CEO and President
Sold, plan not stated
$43.78K 12,156 at 3.60
8.8%
27 May 2021
Delaney William E IV Chief Scientific Officer
Sold, plan not stated
$16.64K 4,129 at 4.03
7.2%
14 Dec 2020
Papkoff Jacqueline Sybil SVP-CSO Microbiome
Sold, plan not stated
$7.98K 1,297 at 6.15
3.4%
9 Nov 2020
Stamm Luisa M Chief Medical Officer
Sold, plan not stated
$22.40K 4,397 at 5.10
36.6%
7 Aug 2020
McHutchison John G CEO and President
Sold, plan not stated 2×
$264.92K 12,151 at 21.80
8.1%
31 Mar 2020
Colonno Richard James EVP & CSO, Virology Ops
Sold, plan not stated
$117.52K 7,812 at 15.04
5.4%
30 Mar 2020
Papkoff Jacqueline Sybil SVP-CSO Microbiome
Sold, plan not stated
$17.83K 1,254 at 14.22
3.1%
13 Dec 2019
Papkoff Jacqueline Sybil SVP-CSO Microbiome
Sold, plan not stated
$30.66K 1,460 at 21.00
6.0%
12 Dec 2019
Colonno Richard James EVP & CSO, Virology Ops
Sold, plan not stated
$826.58K 33,061 at 25.00
20.5%
6 Sep 2018
Lopatin Uri A Chief Med. Off., VP Res. Dev.
Sold, plan not stated
$13.44K 336 at 40.01
0.1%
5 Sep 2018
Lopatin Uri A Chief Med. Off., VP Res. Dev.
Sold, plan not stated
$609.55K 15,204 at 40.09
2.4%
19 Jul 2018
Small Derek A CEO and President
Bought 2×
$99.55K 2,400 at 41.48
0.4%
First buy on file
2 Jul 2018
RINGO WILLIAM R Director
Sold, plan not stated
$38.50K 1,000 at 38.50
4.9%
1 Jun 2018
RINGO WILLIAM R Director
Sold, plan not stated
$42.47K 1,000 at 42.47
4.9%
1 May 2018
RINGO WILLIAM R Director
Sold, plan not stated
$43.06K 1,000 at 43.06
4.9%
2 Apr 2018
RINGO WILLIAM R Director
Sold, plan not stated
$49.32K 1,000 at 49.32
4.9%
1 Mar 2018
RINGO WILLIAM R Director
Sold, plan not stated
$56.37K 1,000 at 56.37
4.9%
1 Feb 2018
RINGO WILLIAM R Director
Sold, plan not stated
$46.86K 1,000 at 46.86
4.9%
2 Jan 2018
RINGO WILLIAM R Director
Sold, plan not stated
$45.04K 1,000 at 45.04
4.9%
1 Dec 2017
RINGO WILLIAM R Director
Sold, plan not stated
$49.37K 1,000 at 49.37
4.9%
1 Nov 2017
RINGO WILLIAM R Director
Sold, plan not stated
$29.55K 1,000 at 29.55
4.9%
16 Oct 2017
RINGO WILLIAM R Director
Sold, plan not stated
$33.70K 1,000 at 33.70
4.9%
12 May 2017
RINGO WILLIAM R Director · indirect
Sold, plan not stated
$76.14K 3,461 at 22.00
100%
Sold half or more
Showing 51–85 of 85. ← Newer Page 2 of 2